Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.52 - $9.59 $1.02 Million - $2.77 Million
288,612 New
288,612 $1.08 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $2.69 Million - $4.55 Million
326,770 New
326,770 $2.73 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $1.98 Million - $3.91 Million
349,391 New
349,391 $2.86 Million
Q1 2022

May 16, 2022

SELL
$8.43 - $20.9 $221,784 - $549,858
-26,309 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $506,711 - $791,374
26,309 New
26,309 $538,000
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $68,694 - $187,816
-19,029 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $50,426 - $76,686
19,029 New
19,029 $66,000
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $2.99 Million - $3.63 Million
-651,043 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $190,802 - $235,539
-38,237 Reduced 5.55%
651,043 $3.36 Million
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $4.44 Million - $5.56 Million
-749,776 Reduced 52.1%
689,280 $4.17 Million
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $9.54 Million - $10.4 Million
1,402,467 Added 3833.03%
1,439,056 $10.4 Million
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $1.74 Million - $3.42 Million
-436,767 Reduced 92.27%
36,589 $271,000
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $1.67 Million - $2.63 Million
473,356 New
473,356 $2.56 Million
Q2 2018

Aug 14, 2018

SELL
$2.11 - $3.92 $42,111 - $78,235
-19,958 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.05 - $3.23 $1,357 - $2,138
662 Added 3.43%
19,958 $41,000
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $36,788 - $77,269
-14,204 Reduced 42.4%
19,296 $51,000
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $107,200 - $186,595
33,500
33,500 $176,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.